Clinical Trial Update: A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Participants With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study of BMS-813160 in combination with chemotherapy or nivolumab for advanced solid tumors has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Pancreatic Cancer

Drugs mentioned

• BMS-813160
• nivolumab (nivolumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Colorectal Cancer, Pancreatic Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-10-09